Nimesulid Leram (Nimesulide)

Nimesulide, the active ingredient in Nimesulid Leram, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for use. It is employed to relieve mild to moderate pain, reduce inflammation, and lower fever in adult patients. It is indicated for conditions such as osteoarthritis, dysmenorrhea, and other inflammatory disorders.

GNH USA supplies Nimesulid Leram as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑supported distribution to meet global demand.

Nimesulide acts on inflammatory pathways to provide analgesic, antipyretic, and anti‑inflammatory effects.

- Mild to moderate pain: alleviates acute or chronic pain by reducing prostaglandin‑mediated sensitization. - Inflammation: decreases swelling and tissue irritation in musculoskeletal and soft‑tissue conditions. - Fever: lowers elevated body temperature associated with inflammatory or infectious processes. - Osteoarthritis: improves joint comfort and function by limiting inflammatory mediators in degenerative joints. - Dysmenorrhea: reduces menstrual cramps through inhibition of uterine prostaglandin synthesis.

Nimesulide may cause a range of adverse reactions, from mild discomfort to serious organ toxicity.

Common Side Effects: - Gastrointestinal discomfort: abdominal pain, dyspepsia, or heartburn. - Nausea and vomiting: feeling sick or expelling stomach contents. - Headache: mild to moderate cranial pain. - Dizziness: transient light‑headedness or vertigo.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or liver injury. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Gastrointestinal ulceration or bleeding. - Acute renal failure or significant decline in kidney function.

Before prescribing Nimesulid Leram, clinicians should consider several safety measures.

- Hypersensitivity: discontinue if allergic reactions such as rash, itching, or swelling occur. - Peptic ulcer disease: avoid in patients with active ulcers or a history of gastrointestinal bleeding. - Liver function: monitor hepatic enzymes during prolonged therapy. - Concomitant NSAIDs/anticoagulants: use with caution as bleeding risk may increase. - Elderly patients: start at the lowest effective dose and monitor for adverse events. - Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Nimesulid Leram can interact with several medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - Lithium: elevated lithium serum levels and potential toxicity.

Moderate Interactions (Monitor Closely): - Methotrexate: possible increase in methotrexate toxicity. - SSRIs or SNRIs: additive risk of bleeding.